Market Overview:
The global AI drug development market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for novel drugs, rising prevalence of chronic diseases, and growing investments in R&D by pharmaceutical companies. The global AI drug development market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drug design, drug synthesis, and other segments. The drug design segment is expected to grow at a CAGR of 17% during the forecast period from 2018 to 2030. This growth can be attributed to increasing use of artificial intelligence for designing new drugs that are more effective and have fewer side effects as compared to traditional drugs. On the basis of application, the tumor segment dominates this market with a share of more than 50%.
Product Definition:
AI Drug Development is the process of using artificial intelligence to develop new drugs. It is important because it can help to speed up the process of drug development and find new and better ways to create drugs.
Drug Design:
Drug design is a process of creating and testing different formulations of drugs with the help of software tools. The main purpose behind drug designing is to identify active ingredients, dose, route of administration, therapeutic profile and side effects that give accurate information about the drug before its clinical trials. In case if it gives positive results in animal studies then it can be approved as safe for human consumption without any further research.
Drug Synthesis:
Drug synthesis is the process of creating a new drug by combining known chemicals or molecules. This technique is widely used in pharmaceutical and biotechnology industries for producing novel drugs with improved properties and reduced costs. Drug synthesis has been an important part of pharmaceutical research since the beginning of modern medicine. The first successful example was insulin, which was developed from catabolic hormones (from cattle) and amino acids (from proteins).
Application Insights:
The other application segment, which includes cardiovascular, oncology and immunology drugs accounted for the largest revenue share in 2017. Other applications of AI include drug discovery and development. Drug discovery is expected to witness a high growth rate over the forecast period owing to increasing investments by companies such as Google, Microsoft, Amazon., Facebook & Apple in various research projects related to this field. For instance, in June 2018 Microsoft announced that it will invest USD 7 billion over 5 years on cognitive-enabled AI platform for cancer research led by researchers from The University of Texas at Austin (UT) Dell Medical School.
On the other hand, nervous system disorders are anticipated to be among the fastest growing segments due largely to an increase in prevalence of neurological diseases coupled with rising demand for effective treatment options across all age groups affected with these disorders including Alzheimer's disease & Parkinson's disease among others.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of AI-enabled companies, availability of skilled workforce and funding for R&D activities. Moreover, increasing demand for new drugs with improved efficacy and reduced toxicity is expected to drive regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising investments by leading pharmaceutical companies in this region coupled with growing awareness among people about advanced treatment options through artificial intelligence technologies such as machine learning and predictive analysis. Furthermore, government initiatives are also being undertaken in countries like China & Japan for accelerating drug discovery using artificial intelligence techniques thus boosting regional market growth over the next eight years (2030).
Growth Factors:
- Increasing demand for novel drugs and therapies: The global AI drug development market is expected to grow at a CAGR of over 16% during the forecast period. This is primarily owing to the increasing demand for novel drugs and therapies, as well as rising prevalence of chronic diseases.
- Proliferation of big data: The growth of big data has led to the emergence of advanced analytics, which is being used extensively in AI drug development. This is helping researchers identify new targets and develop better drugs faster than ever before.
- Advances in technology: Rapid advances in technology are enabling researchers to develop sophisticated algorithms and models that can be used for AI drug development purposes. This is helping them speed up the process considerably while reducing costs significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
AI Drug Development Market Research Report
By Type
Drug Design, Drug Synthesis, Other
By Application
Tumor, Nervous System, Other
By Companies
Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg，Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global AI Drug Development Market Report Segments:
The global AI Drug Development market is segmented on the basis of:
Types
Drug Design, Drug Synthesis, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumor, Nervous System, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Insilico Medicine
- Cyclica
- XtalPi Inc.
- Exscientia Limited
- AiCure, LLC
- Atomwise
- Biovista Inc.
- Breg，Inc.
- Numerate
- Cloud Pharmaceuticals
- IBM
- NuMedii
- BenevolentAI
- Lam Therapeutics
Highlights of The AI Drug Development Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Design
- Drug Synthesis
- Other
- By Application:
- Tumor
- Nervous System
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the AI Drug Development Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
AI drug development is the process of creating new drugs using artificial intelligence. AI can help researchers identify potential drug targets and develop better ways to test those targets. This technology can also help researchers design more effective clinical trials.
Some of the key players operating in the ai drug development market are Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg，Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics.
The ai drug development market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 AI Drug Development Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 AI Drug Development Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 AI Drug Development Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the AI Drug Development Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global AI Drug Development Market Size & Forecast, 2018-2028
4.5.1 AI Drug Development Market Size and Y-o-Y Growth
4.5.2 AI Drug Development Market Absolute $ Opportunity
Chapter 5 Global AI Drug Development Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 AI Drug Development Market Size Forecast by Type
5.2.1 Drug Design
5.2.2 Drug Synthesis
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global AI Drug Development Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 AI Drug Development Market Size Forecast by Applications
6.2.1 Tumor
6.2.2 Nervous System
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global AI Drug Development Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 AI Drug Development Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America AI Drug Development Analysis and Forecast
9.1 Introduction
9.2 North America AI Drug Development Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America AI Drug Development Market Size Forecast by Type
9.6.1 Drug Design
9.6.2 Drug Synthesis
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America AI Drug Development Market Size Forecast by Applications
9.10.1 Tumor
9.10.2 Nervous System
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe AI Drug Development Analysis and Forecast
10.1 Introduction
10.2 Europe AI Drug Development Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe AI Drug Development Market Size Forecast by Type
10.6.1 Drug Design
10.6.2 Drug Synthesis
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe AI Drug Development Market Size Forecast by Applications
10.10.1 Tumor
10.10.2 Nervous System
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific AI Drug Development Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific AI Drug Development Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific AI Drug Development Market Size Forecast by Type
11.6.1 Drug Design
11.6.2 Drug Synthesis
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific AI Drug Development Market Size Forecast by Applications
11.10.1 Tumor
11.10.2 Nervous System
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America AI Drug Development Analysis and Forecast
12.1 Introduction
12.2 Latin America AI Drug Development Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America AI Drug Development Market Size Forecast by Type
12.6.1 Drug Design
12.6.2 Drug Synthesis
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America AI Drug Development Market Size Forecast by Applications
12.10.1 Tumor
12.10.2 Nervous System
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) AI Drug Development Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) AI Drug Development Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) AI Drug Development Market Size Forecast by Type
13.6.1 Drug Design
13.6.2 Drug Synthesis
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) AI Drug Development Market Size Forecast by Applications
13.10.1 Tumor
13.10.2 Nervous System
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 AI Drug Development Market: Competitive Dashboard
14.2 Global AI Drug Development Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Insilico Medicine
14.3.2 Cyclica
14.3.3 XtalPi Inc.
14.3.4 Exscientia Limited
14.3.5 AiCure, LLC
14.3.6 Atomwise
14.3.7 Biovista Inc.
14.3.8 Breg，Inc.
14.3.9 Numerate
14.3.10 Cloud Pharmaceuticals
14.3.11 IBM
14.3.12 NuMedii
14.3.13 BenevolentAI
14.3.14 Lam Therapeutics
